Literature DB >> 10798645

Visual function and subjective quality of life compared in subjects with acquired macular disease.

C A Hazel1, K L Petre, R A Armstrong, M T Benson, N A Frost.   

Abstract

PURPOSE: To determine the objective measures of visual function that are most relevant to subjective quality of vision and perceived reading ability in patients with acquired macular disease.
METHODS: Twenty-eight patients with macular disease underwent a comprehensive assessment of visual function. The patients also completed a vision-related quality-of-life questionnaire that included a section of general questions about perceived visual performance and a section with specific questions on reading.
RESULTS: Results of all tests of vision correlated highly with reported vision-related quality-of-life impairment. Low-contrast tests explained most of the variance in self-reported problems with reading. Text-reading speed correlated highly with overall concern about vision.
CONCLUSIONS: Reading performance is strongly associated with vision-related quality of life. High-contrast distance acuity is not the only relevant measure of visual function in relation to the perceived visual performance of a patient with macular disease. The results suggest the importance of print contrast, even over print size, in reading performance in patients with acquired macular disease.

Entities:  

Mesh:

Year:  2000        PMID: 10798645

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

1.  Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability.

Authors:  Eva Stifter; Franz König; Thomas Lang; Peter Bauer; Sibylla Richter-Müksch; Michaela Velikay-Parel; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-10       Impact factor: 3.117

2.  Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.

Authors:  L Tejeria; R A Harper; P H Artes; C M Dickinson
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

3.  Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Cynthia A Toth; Deborah J Lapolice; Avie D Banks; Sandra S Stinnett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-05       Impact factor: 3.117

4.  Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).

Authors:  Jan Mitchell; Clare Bradley
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

5.  Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

Authors:  Focke Ziemssen; Matthias Lüke; Karl U Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

6.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 7.  Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Authors:  Mary Kay Margolis; Karin Coyne; Tessa Kennedy-Martin; Timothy Baker; Oliver Schein; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Assessing reading performance in the periphery with a Bayesian adaptive approach: The qReading method.

Authors:  Timothy G Shepard; Fang Hou; Peter J Bex; Luis A Lesmes; Zhong-Lin Lu; Deyue Yu
Journal:  J Vis       Date:  2019-05-01       Impact factor: 2.240

9.  Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.

Authors:  Michael Janusz Koss; Peter Kurz; Theoharis Tsobanelis; Walter Lehmacher; Cordula Fassbender; Reinhard Klingel; Frank H J Koch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-23       Impact factor: 3.117

10.  Metamorphopsia in patients with macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Frank G Holz; Hendrik P N Scholl
Journal:  Doc Ophthalmol       Date:  2009-08-27       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.